{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:19Z","timestamp":1789609099606,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T16:22:41Z","timestamp":1691684561000},"page":"5763-5768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccine patterns among patients diagnosed with Guillain-Barr\u00e9 Syndrome and matched counterparts in a Medicare supplemental population, 2000\u20132020"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-3807","authenticated-orcid":false,"given":"Samantha R.","family":"Eiffert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn T.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Traub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha R.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Kinlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2023.08.014_b0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1016\/j.vaccine.2023.08.014_b0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","article-title":"Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study","volume":"13","author":"Kwong","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.014_b0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain-Barr\u00e9 Syndrome in the United States, 1979\u20131980 and 1980\u20131981: lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.vaccine.2023.08.014_b0020","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 Syndrome and the 1992\u20131993 and 1993\u20131994 Influenza Vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.014_b0025","unstructured":"ACIP Contraindications Guidelines for Immunization | CDC. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/contraindications.html [accessed July 2, 2021]."},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.014_b0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.73.3.348","article-title":"Risk of relapse of Guillain-Barr\u00e9 syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation [7]","volume":"73","author":"Pritchard","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.014_b0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","article-title":"Recurrences, vaccinations and long-term symptoms in GBS and CIDP","volume":"14","author":"Kuitwaard","year":"2009","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.014_b0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/cir960","article-title":"Recurrent guillain-barr\u00e9 syndrome following vaccination","volume":"54","author":"Baxter","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.014_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-019-00596-1","article-title":"Vaccines and the risk of Guillain-Barr\u00e9 syndrome","volume":"35","author":"Chen","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.014_b0050","article-title":"Patients\u2019 attitude towards vaccination after Guillain Barr\u00e9 syndrome","volume":"4","author":"Holtz","year":"2021","journal-title":"Heal Sci Reports"},{"key":"10.1016\/j.vaccine.2023.08.014_b0055","article-title":"Rate of recurrent Guillain-Barr\u00e9 Syndrome after mRNA COVID-19 vaccine BNT162b2","author":"David","year":"2021","journal-title":"JAMA Neurol."},{"issue":"43","key":"10.1016\/j.vaccine.2023.08.014_b0060","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1016\/j.vaccine.2019.08.045","article-title":"Surveillance for Guillain-Barr\u00e9 syndrome after 2015\u20132016 and 2016\u20132017 influenza vaccination of Medicare beneficiaries","volume":"37","author":"Arya","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.014_b0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/aje\/kwt051","article-title":"Chart-confirmed Guillain-Barr\u00e9 Syndrome after 2009 H1N1 influenza vaccination among the medicare population, 2009\u20132010","volume":"178","author":"Polakowski","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.014_b0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barr\u00e9 Syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2023.08.014_b0075","unstructured":"Adult Immunization Schedule by Vaccine and Age Group | CDC. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html [accessed July 28, 2021]."},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.014_b0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/aje\/kwu289","article-title":"Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count","volume":"181","author":"Dong","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.08.014_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwad031","article-title":"Inverse probability weighting to estimate exposure effects on the burden of recurrent outcomes in the presence of competing events","author":"Gaber","year":"2023","journal-title":"Am J Epidemiol."},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.014_b0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/M20-6315","article-title":"Comparative effectiveness and harms of antibiotics for outpatient diverticulitis: two nationwide cohort studies","volume":"174","author":"Gaber","year":"2021","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.014_b0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.014_b0100","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in medicare data: development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.014_b0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in non-experimental research","volume":"6","author":"Brookhart","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.014_b0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","article-title":"Adjusted survival curves with inverse probability weights","volume":"75","author":"Cole","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.014_b0115","doi-asserted-by":"crossref","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2023.08.014_b0120","unstructured":"Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS \u00ae: 335-2012."},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.014_b0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.vaccine.2006.09.041","article-title":"Influenza- and RSV-associated hospitalizations among adults","volume":"25","author":"Mullooly","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.014_b0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amepre.2014.10.016","article-title":"Medicare claims versus beneficiary self-report for influenza vaccination surveillance","volume":"48","author":"Lochner","year":"2015","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.014_b0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.amepre.2022.06.002","article-title":"Influenza vaccination coverage among medicare fee-for-service beneficiaries","volume":"63","author":"Tsai","year":"2022","journal-title":"Am J Prev Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T13:46:25Z","timestamp":1736343985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009477"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine patterns among patients diagnosed with Guillain-Barr\u00e9 Syndrome and matched counterparts in a Medicare supplemental population, 2000\u20132020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}